Atlas Trials

Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

Clinical trial NCT02924337 · COMPLETED

Trial details

NCT number
NCT02924337
Sponsor
Poxel SA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Qt Interval, Variation in
Start date
2016-09-01
Primary completion
2016-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.